Grant: Master's Award: Canada Graduate Scholarships
University of Calgary
$17,500.00
B Lymphocytes are Critical Regulators of Pulmonary Inflammation
EF 2016-17
Résumé
Acute and chronic respiratory diseases remain top killers of Canadians and cost the health care system billions of dollars annually. This includes common diseases such as asthma and emphysema and less common problems such as autoimmune and interstitial lung diseases (ILD). Despite these diseases having unique causes, they have a common pathological issue of dysregulated inflammation. Cellular recruitment is a hallmark of acute (neutrophil infiltration) and chronic (lymphocyte infiltration) inflammation. We discovered that a population of neutrophils residing in the lung capillaries act as vascular sentries (under peer review at Science Translation Medicine 2016). These patrolling neutrophils are aged and have a high pro-inflammatory capacity requiring specific regulation to maintain homeostasis. This regulatory process requires B cells to directly induce cell death in aging, activated patrolling neutrophils within the lung capillary network (submitted at Nature Immunology 2016). Resulting from these two manuscripts is an interesting finding that will form the basis of the proposed research. Depleting B cells acutely induces neutrophilic pulmonary inflammation, which results in a T cell chronic interstitial inflammatory process if the B cells are then chronically depleted. The research proposal will investigate biological mechanisms underlying how B cells, conventionally thought to function solely as antibody producers, regulate inflammation in the lung, both acutely and chronically. We propose that a specific regulatory B cell, expressing anti-inflammatory molecule PD-L1, controls pulmonary inflammatory processes and, when absent or dysfunctional, leads to unregulated acute and chronic inflammation.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
367288
Name
Podstawka John
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
B Lymphocytes are Critical Regulators of Pulmonary Inflammation
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
B Cell; Chronic; Immune Response; Immunology; In Vivo; Innate; Leukocyte; Neutrophil; Pulmonary; T Cell
Abstract
Acute and chronic respiratory diseases remain top killers of Canadians and cost the health care system billions of dollars annually. This includes common diseases such as asthma and emphysema and less common problems such as autoimmune and interstitial lung diseases (ILD). Despite these diseases having unique causes, they have a common pathological issue of dysregulated inflammation. Cellular recruitment is a hallmark of acute (neutrophil infiltration) and chronic (lymphocyte infiltration) inflammation. We discovered that a population of neutrophils residing in the lung capillaries act as vascular sentries (under peer review at Science Translation Medicine 2016). These patrolling neutrophils are aged and have a high pro-inflammatory capacity requiring specific regulation to maintain homeostasis. This regulatory process requires B cells to directly induce cell death in aging, activated patrolling neutrophils within the lung capillary network (submitted at Nature Immunology 2016). Resulting from these two manuscripts is an interesting finding that will form the basis of the proposed research. Depleting B cells acutely induces neutrophilic pulmonary inflammation, which results in a T cell chronic interstitial inflammatory process if the B cells are then chronically depleted. The research proposal will investigate biological mechanisms underlying how B cells, conventionally thought to function solely as antibody producers, regulate inflammation in the lung, both acutely and chronically. We propose that a specific regulatory B cell, expressing anti-inflammatory molecule PD-L1, controls pulmonary inflammatory processes and, when absent or dysfunctional, leads to unregulated acute and chronic inflammation.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Podstawka, John
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~